On September 19, 2022 Aesther Healthcare Acquisition Corp. ("Aesther") (NASDAQ: AEHA) entered into definitive merger agreement with Ocean Biomedical, Inc. Aesther reported that it has paid, and that Continental Stock Transfer & Trust Company has received, $1,050,000 from Aesther representing the sum needing to be paid by Aesther to extend the date on which Aesther must consummate its initial business combination from September 16, 2022 to December 16, 2022 (Press release, Ocean Biomedical, SEP 19, 2022, View Source [SID1234621465]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!